Moderna Wins UK Patent Dispute Against Pfizer, BioNTech

MT Newswires Live
2025/08/01

Moderna (MRNA) said Friday that the UK Court of Appeal has upheld the validity of its EP'949 patent, affirming an earlier court ruling that the patent was infringed by Pfizer (PFE) and BioNTech's (BNTX) Comirnaty COVID-19 vaccine.

The company said the patent covers one of its "foundational technologies that enables the development of mRNA-based medicines."

Pfizer and BioNTech did not immediately respond to MT Newswires' requests for comments.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10